- Home
- ILPT vs SGMO Comparison
ILPT vs SGMO Comparison
Compare ILPT & SGMO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ILPT
- SGMO
- Stock Information
- Founded
- ILPT 2017
- SGMO 1995
- Country
- ILPT United States
- SGMO United States
- Employees
- ILPT N/A
- SGMO N/A
- Industry
- ILPT Real Estate Investment Trusts
- SGMO Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- ILPT Real Estate
- SGMO Health Care
- Exchange
- ILPT Nasdaq
- SGMO Nasdaq
- Market Cap
- ILPT 262.6M
- SGMO 242.0M
- IPO Year
- ILPT 2018
- SGMO 2000
- Fundamental
- Price
- ILPT $3.81
- SGMO $1.07
- Analyst Decision
- ILPT Buy
- SGMO Buy
- Analyst Count
- ILPT 2
- SGMO 6
- Target Price
- ILPT $10.00
- SGMO $5.17
- AVG Volume (30 Days)
- ILPT 244.4K
- SGMO 3.8M
- Earning Date
- ILPT 02-18-2025
- SGMO 03-12-2025
- Dividend Yield
- ILPT 1.05%
- SGMO N/A
- EPS Growth
- ILPT N/A
- SGMO N/A
- EPS
- ILPT N/A
- SGMO N/A
- Revenue
- ILPT $442,322,000.00
- SGMO $52,291,000.00
- Revenue This Year
- ILPT N/A
- SGMO N/A
- Revenue Next Year
- ILPT $6.87
- SGMO N/A
- P/E Ratio
- ILPT N/A
- SGMO N/A
- Revenue Growth
- ILPT 1.14
- SGMO N/A
- 52 Week Low
- ILPT $3.15
- SGMO $0.30
- 52 Week High
- ILPT $5.45
- SGMO $3.18
- Technical
- Relative Strength Index (RSI)
- ILPT 47.06
- SGMO 37.60
- Support Level
- ILPT $3.84
- SGMO $1.07
- Resistance Level
- ILPT $4.08
- SGMO $1.24
- Average True Range (ATR)
- ILPT 0.14
- SGMO 0.09
- MACD
- ILPT -0.02
- SGMO 0.02
- Stochastic Oscillator
- ILPT 24.21
- SGMO 5.71
About ILPT Industrial Logistics Properties Trust of Beneficial Interest
Industrial Logistics Properties Trust is a real estate investment trust. It owns and leases industrial and logistics properties throughout the United States. The company's investment portfolio includes industrial lands in Hawaii and industrial and logistics properties in other states. Rental revenue is earned from Hawaii Properties and Mainland Properties.
About SGMO Sangamo Therapeutics Inc.
Sangamo Therapeutics Inc is a genomic medicine company committed to translating ground-breaking science into medicines that transform the lives of patients and families afflicted with serious neurological diseases. Its pipeline products include the Priority Neurology Pipeline offers Chronic Neuropathic Pain, Prion Disease, and Neurology; Partnered Programs offer Hemophilia A, Oncology, ALS/FTD, and Huntington's Disease; and Other Pipelines include Fabry Disease, Renal Transplant, Inflammatory Bowel Disease, and Multiple Sclerosis.